7Baggers
 2 Penny Stocks That Wall Street Believes Can Soar Over 200%  Yahoo Finance Tue, 30 Sep 2025 11:30:02 GMT
 TD Cowen Maintains Adverum Biotechnologies(ADVM.US) With Buy Rating  富途牛牛 Thu, 25 Sep 2025 00:31:00 GMT
 Mizuho reiterates Outperform rating on Adverum stock amid positive trial updates  Investing.com Nigeria Wed, 24 Sep 2025 07:00:00 GMT
 Adverum Biotechnologies stock rating reiterated at Buy by H.C. Wainwright  Investing.com Canada Wed, 24 Sep 2025 00:27:39 GMT
 Adverum Biotechnologies Completes Screening for Phase 3 Trial  TipRanks Mon, 22 Sep 2025 07:00:00 GMT
 Trexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM)  Yahoo Finance Sun, 21 Sep 2025 07:00:00 GMT
 published on: 2025-08-29 00:55:12  beatles.ru Thu, 28 Aug 2025 21:56:13 GMT

Adverum Biotechnologies, Inc
(NASDAQ:ADVM) 

ADVM stock logo

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal dis...

Founded: 2006
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends